Avacta Group Plc (LON:AVCT – Get Free Report) shares rose 13.2% on Monday . The stock traded as high as GBX 59.60 ($0.74) and last traded at GBX 58.93 ($0.73). Approximately 1,319,979 shares were traded during mid-day trading, an increase of 11% from the average daily volume of 1,189,764 shares. The stock had previously closed at GBX 52.05 ($0.65).
Avacta Group Stock Up 15.3 %
The company has a market cap of £215.02 million, a P/E ratio of -666.78 and a beta of 1.12. The company has a debt-to-equity ratio of 63.54, a current ratio of 1.29 and a quick ratio of 4.96. The business’s 50 day moving average price is GBX 48.59 and its 200-day moving average price is GBX 58.51.
Avacta Group Company Profile
Avacta Group Plc develops cancer therapies and diagnostics in the United Kingdom, France, North America, South Korea, and rest of Asia and Europe. The company operates through Diagnostics and Therapeutics segments. It develops products based on its proprietary Affimer and pre|CISION technology platforms.
Featured Stories
- Five stocks we like better than Avacta Group
- How is Compound Interest Calculated?
- Cold Front, Hot Stocks: Diesel Prices Propel Energy Leaders
- Insider Selling Explained: Can it Inform Your Investing Choices?
- Sustainable and Successful: 3 Climate ETFs Beating the Market
- What Are Dividend Achievers? An Introduction
- Quantum Opportunity: Skywater Technology’s Long-Term Potential
Receive News & Ratings for Avacta Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avacta Group and related companies with MarketBeat.com's FREE daily email newsletter.
